Contact us today for a FREE no-obligation initial consultation

law done differently!

Tag

Androgel Settlement Archives | James Esparza Law Group

Mar 29
0

Testosterone Drug Lawsuits Settled by Endo, Glaxo

By | Testosterone, Uncategorized

Testosterone Lawsuit Settlement

More than 1,300 testosterone drug lawsuits were settled following an agreement with plaintiffs and manufacturers, Endo Pharmaceuticals Inc., GlaxoSmithKline LLC and its Auxilium unit, according to Bloomberg News. The lawsuits did not cover cases against AbbVie Inc., the biggest manufacturer of testosterone replacement drugs and the maker of AndroGel. However, it will result in resolution of about 22 percent of the testosterone drug lawsuits pending in a multi-district litigation in a federal court in Chicago.testosterone drug lawsuit

Plaintiffs in these cases allege pharmaceutical companies concealed the dangers of these testosterone-boosting medications in their marketing to middle-aged men.

The terms of the deal (which is tentative) weren’t released, but we do know the male plaintiffs in these cases alleged the drug that was made by Endo and promoted by Glaxo had the potential to cause deadly blood clots. A spokeswoman for the manufacturers said the settlement deal will not require the drug makers to admit any liability or wrongdoing. However, it will result in a payout to those individuals harmed by the drug, including those whose loved ones died while taking the drug. Read More

Oct 05
0

Androgel Lawsuit Update – Androgel User Awarded $140 Million

By | Androgel, Testosterone

$140 Million Awarded In 2nd Androgel User Trial

The second Androgel lawsuit has concluded with a jury in Chicago awarding Jeffrey Konrad $140 Million in punitive damages and $140,000.00 for actual damages for injuries incurred from Androgel use. Mr. Konrad suffered a heart attack after several months of Androgel use. The jury found in favor of Mr. Konrad on claims of negligence, intentional misrepresentation and misrepresentation by concealment.

The trial started on September 18, 2017 before the Honorable Matthew Kennelly. The jury started deliberation on October 3 and reached a decision on October 5 after two days of deliberation.

This is the second damaging jury decision involving Androgel and AbbVie Inc. In the Mitchell case the jury awarded $150 Million to the Androgel user. Based on the two jury decisions it appears that the marketing efforts of AbbVie Inc. is a substantial issue in Androgel Lawsuits.

Thousands of former Androgel users have alleged that their use of Androgel caused them to have heart attacks, strokes, and pulmonary embolisms. The next Androgel trial is scheduled for January, 2018.

Androgel Lawsuit Information – We Can Help Androgel Users

Many clients contact us not knowing if their heart attack, stroke, or pulmonary embolism was caused by their use of Androgel. If you are in a similar situation contact us with your questions.  If you select us to represent you we will thoroughly evaluate your case, assess the strengths and weakness and let you know the best course of action. Call us at 1-800-745-4050.

 

Jul 26
0

$150 Million Androgel Verdict – Are Settlements Near?

By | Testosterone

Jury Awards $150 Million to Androgel® Victim

In the second trial involving Androgel a jury in the Northern District of Illinois awarded Jessee Mitchell $150 million in punitive damages. The jury, however, failed to award Mr. Mitchell any damages for his personal injury.  The jury found that the Androgel label was adequate.

The substantial jury award will be viewed as a win for the thousands of Androgel users who suffered serious injuries while using Androgel and who are awaiting for their day in court.  The jury specifically found that AbbVie fraudently marketed Androgel by creating the condition “Low T.”

However, the verdict is also a win for AbbVie as the jury concluded that the label was adequate. Most pharmaceutical product liability claims pivot on the issue of whether the manufacturer of the prescription medicine properly warned of the risks associated with the product. Thus, the confusing message the jury has sent will cause attorneys for Androgel victims and AbbVie to speculate about future cases.

Androgel Settlements

Androgel cases were consolidated into MDL 2545 In Re: Testosterone Replacement Therapy Products Liability Litigation in 2014.  There are approximately 6,000 cases pending before Judge Matthew F. Kennelly. Androgel lawsuits involve heart attack, stroke, deep vein thrombosis and death. The next Androgel trial is set to start on August 28, 2017.

With the mixed verdict of the jury settlement values remain elusive.  However,

We Can Help Still Help Androgel Users

James Esparza has been actively involved in Androgel lawsuits since 2014. If you or a loved one has suffered a heart attack, stroke, pulmonary embolism, deep vein thrombosis or death while using Androgel we can help. You can reach James at 1-800-745-4050.

 

Top